vs

Side-by-side financial comparison of Essex Property Trust (ESS) and INSMED Inc (INSM). Click either name above to swap in a different company.

Essex Property Trust is the larger business by last-quarter revenue ($479.6M vs $263.8M, roughly 1.8× INSMED Inc). Essex Property Trust runs the higher net margin — 17.9% vs -124.5%, a 142.4% gap on every dollar of revenue. On growth, INSMED Inc posted the faster year-over-year revenue change (152.6% vs 5.5%). Over the past eight quarters, INSMED Inc's revenue compounded faster (86.9% CAGR vs 6.0%).

Essex Property Trust is a publicly traded real estate investment trust that invests in apartments in California and in the Seattle metropolitan area.

Insmed Inc. is a global biopharmaceutical firm focused on developing and commercializing innovative therapies for patients with serious rare diseases that have high unmet medical needs. Its key offerings target pulmonary and endocrine rare disorders, serving markets across North America, Europe, and Asia Pacific.

ESS vs INSM — Head-to-Head

Bigger by revenue
ESS
ESS
1.8× larger
ESS
$479.6M
$263.8M
INSM
Growing faster (revenue YoY)
INSM
INSM
+147.1% gap
INSM
152.6%
5.5%
ESS
Higher net margin
ESS
ESS
142.4% more per $
ESS
17.9%
-124.5%
INSM
Faster 2-yr revenue CAGR
INSM
INSM
Annualised
INSM
86.9%
6.0%
ESS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ESS
ESS
INSM
INSM
Revenue
$479.6M
$263.8M
Net Profit
$85.7M
$-328.5M
Gross Margin
70.0%
83.2%
Operating Margin
31.7%
-121.2%
Net Margin
17.9%
-124.5%
Revenue YoY
5.5%
152.6%
Net Profit YoY
-71.6%
-39.5%
EPS (diluted)
$1.24
$-1.55

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ESS
ESS
INSM
INSM
Q4 25
$479.6M
$263.8M
Q3 25
$473.3M
$142.3M
Q2 25
$469.8M
$107.4M
Q1 25
$464.6M
$92.8M
Q4 24
$454.5M
$104.4M
Q3 24
$450.7M
$93.4M
Q2 24
$442.4M
$90.3M
Q1 24
$426.9M
$75.5M
Net Profit
ESS
ESS
INSM
INSM
Q4 25
$85.7M
$-328.5M
Q3 25
$172.7M
$-370.0M
Q2 25
$231.5M
$-321.7M
Q1 25
$212.8M
$-256.6M
Q4 24
$301.7M
$-235.5M
Q3 24
$125.5M
$-220.5M
Q2 24
$99.0M
$-300.6M
Q1 24
$285.1M
$-157.1M
Gross Margin
ESS
ESS
INSM
INSM
Q4 25
70.0%
83.2%
Q3 25
69.2%
79.4%
Q2 25
70.7%
73.9%
Q1 25
69.6%
77.1%
Q4 24
70.0%
75.0%
Q3 24
69.5%
77.3%
Q2 24
70.8%
76.8%
Q1 24
69.7%
76.9%
Operating Margin
ESS
ESS
INSM
INSM
Q4 25
31.7%
-121.2%
Q3 25
44.5%
-257.1%
Q2 25
59.5%
-291.3%
Q1 25
55.3%
-267.3%
Q4 24
67.0%
-220.6%
Q3 24
28.6%
-228.4%
Q2 24
31.1%
-319.8%
Q1 24
31.0%
-192.7%
Net Margin
ESS
ESS
INSM
INSM
Q4 25
17.9%
-124.5%
Q3 25
36.5%
-260.0%
Q2 25
49.3%
-299.5%
Q1 25
45.8%
-276.4%
Q4 24
66.4%
-225.5%
Q3 24
27.8%
-236.0%
Q2 24
22.4%
-332.8%
Q1 24
66.8%
-208.1%
EPS (diluted)
ESS
ESS
INSM
INSM
Q4 25
$1.24
$-1.55
Q3 25
$2.56
$-1.75
Q2 25
$3.44
$-1.70
Q1 25
$3.16
$-1.42
Q4 24
$4.00
$-1.30
Q3 24
$1.84
$-1.27
Q2 24
$1.45
$-1.94
Q1 24
$4.25
$-1.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ESS
ESS
INSM
INSM
Cash + ST InvestmentsLiquidity on hand
$76.2M
$1.4B
Total DebtLower is stronger
$546.8M
Stockholders' EquityBook value
$5.5B
$739.0M
Total Assets
$13.2B
$2.3B
Debt / EquityLower = less leverage
0.74×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ESS
ESS
INSM
INSM
Q4 25
$76.2M
$1.4B
Q3 25
$66.0M
$1.7B
Q2 25
$58.7M
$1.9B
Q1 25
$98.7M
$1.2B
Q4 24
$66.8M
$1.4B
Q3 24
$71.3M
$1.5B
Q2 24
$55.2M
$1.2B
Q1 24
$499.0M
$595.7M
Total Debt
ESS
ESS
INSM
INSM
Q4 25
$546.8M
Q3 25
$6.4B
$546.8M
Q2 25
$6.4B
$546.8M
Q1 25
$6.8B
$1.1B
Q4 24
$1.1B
Q3 24
$6.4B
$971.8M
Q2 24
$6.2B
$1.2B
Q1 24
$6.6B
$1.2B
Stockholders' Equity
ESS
ESS
INSM
INSM
Q4 25
$5.5B
$739.0M
Q3 25
$5.6B
$945.6M
Q2 25
$5.6B
$1.2B
Q1 25
$5.6B
$99.2M
Q4 24
$5.5B
$285.4M
Q3 24
$5.4B
$483.4M
Q2 24
$5.5B
$38.8M
Q1 24
$5.5B
$-464.8M
Total Assets
ESS
ESS
INSM
INSM
Q4 25
$13.2B
$2.3B
Q3 25
$13.2B
$2.4B
Q2 25
$13.2B
$2.5B
Q1 25
$13.2B
$1.8B
Q4 24
$12.9B
$2.0B
Q3 24
$12.6B
$2.1B
Q2 24
$12.5B
$1.8B
Q1 24
$12.9B
$1.2B
Debt / Equity
ESS
ESS
INSM
INSM
Q4 25
0.74×
Q3 25
1.15×
0.58×
Q2 25
1.14×
0.44×
Q1 25
1.22×
11.31×
Q4 24
3.93×
Q3 24
1.18×
2.01×
Q2 24
1.13×
30.66×
Q1 24
1.19×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ESS
ESS
INSM
INSM
Operating Cash FlowLast quarter
$1.1B
$-247.6M
Free Cash FlowOCF − Capex
$-264.2M
FCF MarginFCF / Revenue
-100.1%
Capex IntensityCapex / Revenue
6.3%
Cash ConversionOCF / Net Profit
12.53×
TTM Free Cash FlowTrailing 4 quarters
$-967.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ESS
ESS
INSM
INSM
Q4 25
$1.1B
$-247.6M
Q3 25
$342.6M
$-219.8M
Q2 25
$216.1M
$-205.6M
Q1 25
$281.5M
$-262.1M
Q4 24
$1.1B
$-196.0M
Q3 24
$316.2M
$-180.9M
Q2 24
$218.9M
$-123.0M
Q1 24
$314.9M
$-184.0M
Free Cash Flow
ESS
ESS
INSM
INSM
Q4 25
$-264.2M
Q3 25
$-222.2M
Q2 25
$-209.1M
Q1 25
$-272.2M
Q4 24
$-202.8M
Q3 24
$-184.6M
Q2 24
$-129.7M
Q1 24
$-188.7M
FCF Margin
ESS
ESS
INSM
INSM
Q4 25
-100.1%
Q3 25
-156.1%
Q2 25
-194.6%
Q1 25
-293.2%
Q4 24
-194.1%
Q3 24
-197.6%
Q2 24
-143.6%
Q1 24
-250.0%
Capex Intensity
ESS
ESS
INSM
INSM
Q4 25
6.3%
Q3 25
1.7%
Q2 25
3.2%
Q1 25
10.8%
Q4 24
6.5%
Q3 24
3.9%
Q2 24
7.5%
Q1 24
6.2%
Cash Conversion
ESS
ESS
INSM
INSM
Q4 25
12.53×
Q3 25
1.98×
Q2 25
0.93×
Q1 25
1.32×
Q4 24
3.54×
Q3 24
2.52×
Q2 24
2.21×
Q1 24
1.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons